18.11.2014 Views

09/2009 - Državni zavod za intelektualno vlasništvo

09/2009 - Državni zavod za intelektualno vlasništvo

09/2009 - Državni zavod za intelektualno vlasništvo

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

HR - Patenti - Hrvatski glasnik <strong>intelektualno</strong>g vlasništva 16, 20<strong>09</strong>, 9, 3373 – 3601 3511<br />

MKP Broj objave europske Naziv izuma<br />

prijave patenta<br />

(51) (97) (54)<br />

A61K 45/06 (2006.01) EP 2<strong>09</strong>9451 * COMBINATION OF AN HDAC INHIBITOR AND AN ANTIMETABOLITE<br />

A61K 47/00 (2006.01) EP 2<strong>09</strong>4729 * ABETA ANTIBODY PARENTERAL FORMULATION<br />

A61K 47/02 (2006.01) EP 2089002 * PHENYLALKYL CARBAMATE COMPOSITIONS<br />

A61K 47/02 (2006.01) EP 2<strong>09</strong>0310 * ADHESIVE PREPARATION, AND METHOD FOR REDUCING THE PRODUCTION OF<br />

DONEPEZIL ANALOGUE IN DONEPEZIL-CONTAINING SKIN ADHESIVE PREPARATION<br />

METHOD FOR PREVENTION OF COLORATION IN DONEPEZIL-CONTAINING SKIN<br />

A61K 47/02 (2006.01) EP 2<strong>09</strong>4247 * STABLE POLYPEPTIDE FORMULATIONS<br />

A61K 47/02 (2006.01) EP 2<strong>09</strong>8232 * PERCUTANEOUS ABSORPTION PREPARATION<br />

A61K 47/02 (2006.01) EP 2<strong>09</strong>8233 * SKIN ADHESIVE PREPARATION COMPRISING STABILIZED DONEPEZIL<br />

A61K 47/02 (2006.01) EP 2<strong>09</strong>8235 * METHOD FOR PREVENTION OF DISCOLORATION WITH TIME OF DONEPEZIL-<br />

CONTAINING SKIN ADHESIVE PREPARATION<br />

A61K 47/10 (2006.01) EP 2086504 * DICLOFENAC GEL<br />

A61K 47/10 (2006.01) EP 2<strong>09</strong>8233 * SKIN ADHESIVE PREPARATION COMPRISING STABILIZED DONEPEZIL<br />

A61K 47/10 (2006.01) EP 2<strong>09</strong>8234 * SKIN ADHESIVE PREPARATION COMPRISING STABILIZED DONEPEZIL<br />

A61K 47/10 (2006.01) EP 2<strong>09</strong>8235 * METHOD FOR PREVENTION OF DISCOLORATION WITH TIME OF DONEPEZIL-<br />

CONTAINING SKIN ADHESIVE PREPARATION<br />

A61K 47/12 (2006.01) EP 2<strong>09</strong>7068 * FORMULATIONS OF PEG-INTERFERON ALPHA CONJUGATES<br />

A61K 47/14 (2006.01) EP 2<strong>09</strong>8232 * PERCUTANEOUS ABSORPTION PREPARATION<br />

A61K 47/14 (2006.01) EP 2<strong>09</strong>8233 * SKIN ADHESIVE PREPARATION COMPRISING STABILIZED DONEPEZIL<br />

A61K 47/14 (2006.01) EP 2<strong>09</strong>8235 * METHOD FOR PREVENTION OF DISCOLORATION WITH TIME OF DONEPEZIL-<br />

CONTAINING SKIN ADHESIVE PREPARATION<br />

A61K 47/18 (2006.01) EP 2<strong>09</strong>8233 * SKIN ADHESIVE PREPARATION COMPRISING STABILIZED DONEPEZIL<br />

A61K 47/18 (2006.01) EP 2<strong>09</strong>8235 * METHOD FOR PREVENTION OF DISCOLORATION WITH TIME OF DONEPEZIL-<br />

CONTAINING SKIN ADHESIVE PREPARATION<br />

A61K 47/20 (2006.01) EP 2<strong>09</strong>8233 * SKIN ADHESIVE PREPARATION COMPRISING STABILIZED DONEPEZIL<br />

A61K 47/20 (2006.01) EP 2<strong>09</strong>8234 * SKIN ADHESIVE PREPARATION COMPRISING STABILIZED DONEPEZIL<br />

A61K 47/20 (2006.01) EP 2<strong>09</strong>8235 * METHOD FOR PREVENTION OF DISCOLORATION WITH TIME OF DONEPEZIL-<br />

CONTAINING SKIN ADHESIVE PREPARATION<br />

A61K 47/22 (2006.01) EP 2<strong>09</strong>0310 * ADHESIVE PREPARATION, AND METHOD FOR REDUCING THE PRODUCTION OF<br />

DONEPEZIL ANALOGUE IN DONEPEZIL-CONTAINING SKIN ADHESIVE PREPARATION<br />

METHOD FOR PREVENTION OF COLORATION IN DONEPEZIL-CONTAINING SKIN<br />

A61K 47/22 (2006.01) EP 2<strong>09</strong>8233 * SKIN ADHESIVE PREPARATION COMPRISING STABILIZED DONEPEZIL<br />

A61K 47/22 (2006.01) EP 2<strong>09</strong>8234 * SKIN ADHESIVE PREPARATION COMPRISING STABILIZED DONEPEZIL<br />

A61K 47/22 (2006.01) EP 2<strong>09</strong>8235 * METHOD FOR PREVENTION OF DISCOLORATION WITH TIME OF DONEPEZIL-<br />

CONTAINING SKIN ADHESIVE PREPARATION<br />

A61K 47/26 (2006.01) EP 2<strong>09</strong>4236 * GEL USEFUL FOR THE DELIVERY OF OPHTHALMIC DRUGS<br />

A61K 47/26 (2006.01) EP 2<strong>09</strong>4247 * STABLE POLYPEPTIDE FORMULATIONS<br />

A61K 47/26 (2006.01) EP 2<strong>09</strong>6116 * SODIUM SALT OF DISACCHARIDE COMPOUND, METHOD FOR PRODUCING THE SAME,<br />

AND USE OF THE SAME<br />

A61K 47/26 (2006.01) EP 2<strong>09</strong>8233 * SKIN ADHESIVE PREPARATION COMPRISING STABILIZED DONEPEZIL<br />

A61K 47/26 (2006.01) EP 2<strong>09</strong>8234 * SKIN ADHESIVE PREPARATION COMPRISING STABILIZED DONEPEZIL<br />

A61K 47/26 (2006.01) EP 2<strong>09</strong>8235 * METHOD FOR PREVENTION OF DISCOLORATION WITH TIME OF DONEPEZIL-<br />

CONTAINING SKIN ADHESIVE PREPARATION<br />

A61K 47/32 (2006.01) EP 2086504 * DICLOFENAC GEL<br />

A61K 47/32 (2006.01) EP 2<strong>09</strong>4236 * GEL USEFUL FOR THE DELIVERY OF OPHTHALMIC DRUGS<br />

A61K 47/32 (2006.01) EP 2<strong>09</strong>8232 * PERCUTANEOUS ABSORPTION PREPARATION<br />

A61K 47/36 (2006.01) EP 2086504 * DICLOFENAC GEL<br />

A61K 47/38 (2006.01) EP 2086504 * DICLOFENAC GEL<br />

A61K 47/48 (2006.01) EP 2087103 * CANCEROUS DISEASE MODIFYING ANTIBODIES<br />

A61K 47/48 (2006.01) EP 2089060 * LIQUID PREPARATION COMPRISING A COMPLEX OF PIMOBENDAN AND<br />

CYCLODEXTRIN<br />

A61K 47/48 (2006.01) EP 2089514 * CANCEROUS DISEASE MODIFYING ANTIBODIES<br />

A61K 47/48 (2006.01) EP 2<strong>09</strong>2058 * CANCEROUS DISEASE MODIFYING ANTIBODIES<br />

A61K 47/48 (2006.01) EP 2<strong>09</strong>2069 * MODIFIED SOLUBLE FGF RECEPTOR FC FUSIONS WITH IMPROVED BIOLOGICAL<br />

ACTIVITY<br />

A61K 47/48 (2006.01) EP 2<strong>09</strong>7108 * FACTOR IX MOIETY-POLYMER CONJUGATES HAVING A RELEASEABLE LINKAGE<br />

A61K 47/48 (2006.01) EP 2<strong>09</strong>7529 * METHODS OF SELECTING AND PRODUCING MODIFIED TOXINS, CONJUGATES<br />

CONTAINING MODIFIED TOXINS AND USES THEREOF<br />

A61K 47/48 (2006.01) EP 2<strong>09</strong>9495 * CONJUGATES OF A G-CSF MOIETY AND A POLYMER<br />

A61K 48/00 (2006.01) EP 2086591 * EFFICIENT NUCLEAR DELIVERY OF ANTISENSE OLIGONUCLEOTIDES<br />

A61K 48/00 (2006.01) EP 2<strong>09</strong>7517 * MODIFIED VACCINIA VIRUS STRAINS FOR USE IN DIAGNOSTIC AND THERAPEUTIC<br />

METHODS<br />

A61K 48/00 (2006.01) EP 2<strong>09</strong>8595 * HLA-A*1101-RESTRICTED WT1 PEPTIDE AND PHARMACEUTICAL COMPOSITION<br />

COMPRISING THE SAME<br />

A61K 48/00 (2006.01) EP 2<strong>09</strong>9472 * INTRA-VASCULAR KIDNEY GENE THERAPY WITH PLASMID ENCODING BMP-7<br />

ISSN 1331-2030

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!